BTG Overview

  • Founded
  • 1948
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1,600
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 6
  • Investments
  • 19

BTG General Information

Description

BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. The revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.

Contact Information

Website
btgplc.com
Formerly Known As
British Technology Group
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Parent Company
Boston Scientific
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BTG Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BTG‘s full profile, request access.

Request a free trial

BTG Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating
Discovery Tools (Healthcare)
1,600 As of 2019
00000
0.000 0000-00-00
000000&0 00000

00000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
0000 000000000
Mumbai, India
00000 As of 0000
00000000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000000000
Bangalore, India
00000 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BTG Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 00000000
000000 Formerly PE-Backed Bangalore, India 00000 000.00 00000000 000.00
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
000000 00000 Corporation Mumbai, India 0000
000 000000 Corporate Backed or Acquired Monheim, Germany 0000 000000&0
You’re viewing 5 of 9 competitors. Get the full list »

BTG Patents

BTG Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200352945-A1 Platinum-resistant cancer treatment Abandoned 01-Jun-2017 0000000000
US-11026948-B2 Platinum-resistant cancer treatment Active 01-Jun-2017 0000000000 00
US-20210252001-A1 Platinum-resistant cancer treatment Pending 01-Jun-2017 0000000000
EP-3624803-A1 Platinum-resistant cancer treatment Pending 16-May-2017 0000000000
AU-2018268400-A1 Platinum-resistant cancer treatment Pending 16-May-2017 A61K31/517
To view BTG’s complete patent history, request access »

BTG Executive Team (13)

Name Title Board Seat Contact Info
Alex MacKinnon Director, Group Controls
Peter Stratford Ph.D Head of Innovation
Paul McCubbin Head, Strategy
James Matons Vice President Commercial Operations EMEA of Biocompatibles UK
Jamie Heath Chief Development Officer
You’re viewing 5 of 13 executive team members. Get the full list »

BTG Board Members (13)

Name Representing Role Since
00000 00000 Self Chairman & Board Member 000 0000
00000 0000 Self Board Member 000 0000
000000 000000000000 BTG Non-Executive Director 000 0000
000 0'0000 BTG Non-Executive Director 000 0000
00000 00000 00.0 BTG Non-Executive Director 000 0000
You’re viewing 5 of 13 board members. Get the full list »

BTG Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BTG Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BTG‘s full profile, request access.

Request a free trial

BTG Investments & Acquisitions (19)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000 0 18-Jul-2019 00000 0000 000.00 Pharmaceuticals
00000 0000000 13-Nov-2018 00000 0000 0000 Diagnostic Equipment 000000 00
000000 000000 07-Sep-2018 0000000000 00000 Therapeutic Devices 000000 00
0000000 00000 05-Oct-2017 0000000000 0000 Surgical Devices 0000 0000
OncoVerse 24-Apr-2017 Merger/Acquisition Enterprise Systems (Healthcare)
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

BTG Subsidiaries (5)

Company Name Industry Location Founded
PneumRx Therapeutic Devices Mountain View, CA 2004
00000 0000000 Surgical Devices Saint Paul, MN 0000
00000000000000 000 Pharmaceuticals Farnham, United Kingdom 0000
000 0000000 0000 Corporate Pension London, United Kingdom
000 00000000 Corporate Venture Capital London, United Kingdom
To view BTG’s complete subsidiaries history, request access »

BTG Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 0000000 0000 13-Nov-2018 00000 00000 00 0000 Completed
  • 000
00000 000000000000 16-Jan-2008 00000 00000 00 00.00 Completed
  • 14 buyers
0000000000000 29-Jan-2004 00000 00000 00 0000 Completed
  • 4 buyers
00000 000000000000 22-May-2002 00000 00000 00 0000 Completed
  • 6 buyers
Meriton Networks 17-Sep-2001 Early Stage VC 0000 Completed
  • 8 buyers
To view BTG’s complete exits history, request access »